PRODH and neoplasm: PRODH had elevated expression in 4 tumor types (GBMLGG, LGG, SKCM, and SKCM-M) with poor prognosis and low expression in 6 tumors (CESC, LUAD, KIRP, PRAD, KIRC, and LUSC).